Discontinuation report APO-BICALUTAMIDE
Report ID | 157376 |
Drug Identification Number | 02296063 |
Brand name | APO-BICALUTAMIDE |
Common or Proper name | BICALUTAMIDE |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | BICALUTAMIDE |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 BLS |
ATC code | L02BB |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-04-29 |
Actual discontinuation date | 2022-05-12 |
Remaining supply date | 2022-05-11 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Inventory at Apotex is depleted |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-03-25 | English | Compare |
v2 | 2022-03-25 | French | Compare |
v3 | 2022-05-12 | English | Compare |
v4 | 2022-05-12 | French | Compare |
v5 | 2022-05-13 | English | Compare |
Showing 1 to 5 of 5